相关实验视频
Updated: Sep 18, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.7K
在RUNX1-MECOM型白血病细胞中,HDAC抑制剂抑制Tek和Angpt1的表达和增殖
Fumi Nakamura1, Yuka Nakamura1, Ko Sasaki1
1Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
Leukemia research
|June 26, 2025
概括
基因组脱乙酶抑制剂 (HDACi) 显示出治疗RUNX1-MECOM急性大核细胞白血病的前景,通过阻断涉及angiopoietin 1和Tek的自身分泌循环,从而抑制白血病细胞生长.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 由t(3;21) 转位产生的RUNX1-MECOM融合基因是急性巨核细胞白血病的关键驱动因素.
- RUNX1-MECOM招募基因组脱乙酶 (HDAC) 来发挥其致癌功能.
- 之前的研究建立了一个用于白血病研究的RUNX1-MECOM小鼠模型.
研究的目的:
- 在RUNX1-MECOM白血病中调查 ангиопоэтин 1 (Angpt1) 和Tek的作用.
- 在这个白血病模型中评估组胺脱乙酶抑制剂 (HDACi) 的治疗潜力.
主要方法:
- 定量RT-PCR阵列和Angpt1和Tek表达的蛋白质确认.
- 使用Angpt1进行刺激测定,以评估下游信号 (Tek和Akt酸化).
- 在体外和体内使用HDAC抑制剂 (trichostatin A和valproic acid) 对白血病细胞和小鼠进行的研究.
主要成果:
- RUNX1-MECOM白血病细胞显示Angpt1和Tek的表达升高,形成潜在的自身隐性循环.
- HDAC抑制剂 (TSA,VPA) 降低了Angpt1和Tek的调节,抑制了白血病细胞的生长,诱导了细胞循环停止,细胞亡和部分巨核细胞分化.
- 瓦尔酸 (VPA) 治疗延长了二次移植小鼠的存活时间.
结论:
- HDAC 抑制剂可以通过破坏 Angpt1-Tek 自克林循环来抵消 RUNX1-MECOM 白血病.
- 作为RUNX1-MECOM型白血病的向治疗,HDACi显示出治疗潜力.
更多相关视频
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
Master Transcription Regulators
7.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Co-activators and Co-repressors
7.6K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.6K

